On 1st February 2012 Jean Cater from the Leverhulme Trust is coming to BU.
This is a fantastic opportunity to find out more about how the Leverhulme works, what they are looking for in a proposal and what they fund.
The Leverhulme Trust offers a range of funding opportunities – across all disciplines. This includes research grants, international networks, early career fellowships, research fellowships and more.
The session will cover:
- where the Leverhulme sits in the funding spectrum
- schemes and application procedures
- things to bear in mind if applying
- plenty of time to ask questions too.
This session is for you if:
- you have a research idea and wonder if the Leverhulme Trust might be an appropriate funder
- you are developing a funding proposal for the Leverhulme Trust
- you don’t know much about the Leverhulme Trust and would like to find out more
Details:
- Date: Wednesday, 1st February 2012
- Time: 2-4pm
- Place: Thomas Hardy Suite – PG 146
Information about how to book will come in January 2012. There is limited space so please watch this space for more information.
In the meantime, if you have any questions please email Caroline O’Kane











BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease